Clinical trial
FRAGRANCE Part A Safety: Study to Find a Genetic Signature of de Novo Resistance…
NCT00199134 · Jules Bordet Institute, Other · Completed
Key facts
| NCT number | NCT00199134 |
|---|---|
| Title | FRAGRANCE Part A Safety: Study to Find a Genetic Signature of de Novo Resistance to Letrozole |
| Official title | FRAGRANCE Trial(Femara Reanalysed Through Genomics for Response Assessment, Calibration and Empowerment) |
| Lead sponsor | Jules Bordet Institute, Other |
| Collaborators | Feculdade de Medicina da Universidade de Sao Paulo - Brasil Hospital de Clinicas de Porto Alegre Hospital do Cancer, Sao Paulo |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Letrozole |
| Enrollment | 49 |
| Start date | Nov 1, 2004 |
| Primary completion | Dec 1, 2014 |
| Completion | Dec 1, 2014 |
| First posted | Sep 20, 2005 |
| Last update posted | Jan 6, 2015 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: